Detalles de la búsqueda
1.
Role of cellular, molecular and tumor microenvironment in hepatocellular carcinoma: Possible targets and future directions in the regorafenib era.
Int J Cancer
; 147(7): 1778-1792, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162677
2.
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy.
Cancer Immunol Res
; 12(4): 400-412, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38260999
3.
Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy.
bioRxiv
; 2023 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36747853
4.
CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway.
Sci China Life Sci
; 65(10): 1998-2016, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35380342
5.
Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma.
J Natl Cancer Inst
; 114(9): 1301-1305, 2022 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35288743
6.
Pancreatic Leiomyosarcoma With Schistosomiasis Hematobia: A Case Report and Literature Review.
Front Oncol
; 11: 638905, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33869026
7.
Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment.
Ther Adv Med Oncol
; 13: 17588359211018026, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34104226
8.
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma.
J Immunother Cancer
; 8(2)2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33234602
Resultados
1 -
8
de 8
1
Próxima >
>>